| |
14 FEB 2012
COMPENDIA BIOSCIENCE AND H3 BIOMEDICINE ANNOUNCE STRATEGIC COLLABORATION
Compendia Bioscience today announced that it has signed a three-year licensing agreement with H3 Biomedicine, Inc. to Compendia's full suite of Oncomine tools including Oncomine Concepts Edition and Oncomine Power Tools Edition...
 MORE
|
27 JUL 2010
THREE INDEPENDENT STUDIES DEMONSTRATE ASSOCIATION OF 3q26 - 3q28 GENES WITH SQUAMOUS CELL CARCINOMAS.
Although the 3q26 - 3q28 chromosomal region contains many candidate oncogenes (e.g., TP63, PIK3CA, and DCUN1D1) the precise target of recurrent amplifications in this region had, until recently, been undetermined.
MORE
|
An overview of Compendia's leadership, philosophy, news and events, and products and serrvices
 Download PDF
|
|
